2026-08-24
AIRWA INC.
AiRWA Inc. received notice from Nasdaq on August 24, 2026 of failure to file Form 10-K for period ended April 30, 2026, violating Nasdaq Listing Rule 5250(c)(1).
high
Risk API
Tracking listing deficiencies and delisting risk
Item 3.01 is a company disclosing that it has fallen out of compliance with its exchange's listing rules. In our own event study it was the strongest single result we measured.
The problem
A holding receives a deficiency notice from its exchange. It is disclosed in an 8-K the same week, filed under a code that says exactly what it is, and it reaches you a month later through a screen that recalculates quarterly.
Two opposite events share one code
Item 3.01 covers both falling out of compliance and regaining it. A cure notice and a deficiency notice arrive under the same code, so the direction has to come from the text.
The language is exchange-specific
Nasdaq, NYSE and the smaller venues each phrase a deficiency differently, so a keyword rule tuned on one venue quietly misses the others.
It is a sequence, not an event
A deficiency, a compliance plan, an extension and a final determination are separate filings. What you usually want is the whole thread for one CIK.
The request
One callGET /risks/v1/events ?event_type=delisting_risk &min_severity=high &since=2026-03-04
For the full thread on one company, use the by-CIK endpoint instead: it returns full history on every plan, including free.
event_type
delisting_risk, from Item 3.01.
severity
Model-assigned here, precisely because the code cannot separate a deficiency from a cure.
summary
The filing's own account of which rule and which venue.
exchanges
Joined per request from SEC's own map. A list, because a company can carry several symbols.
event_date
When it happened, which for a deficiency is the notice date.
source_url
The filing on sec.gov.
The first 3 rows that call returns
Live, newest first2026-08-27
AZIO AI HOLDINGS, INC.
Nasdaq notified company of failure to obtain shareholder approval for change-of-control transaction completed July 2, 2026. Company remediated by removing four officers effective August 27, 2026.
high
2026-08-26
BioAtla, Inc.
Nasdaq Listing Council affirmed delisting determination on August 26, 2026. Common stock subject to suspension effective August 31, 2026 due to non-compliance with bid price and stockholders' equity requirements.
high
What to know before you build on it
- Read severity as a sorting aid, not a verdict. On this event type the code genuinely cannot tell you the direction, which is the honest reason a model is involved at all.
- Our event study found this the strongest event type in the corpus on the reaction day, and separately found its five-session figure conditioned on survivorship. Base rates about our own history are defensible; forecasts about a security are a different thing entirely and we do not make them.
- Refreshed daily. A notice filed after the pass appears the next morning.
- Not investment advice, and not a compliance determination.
Common questions
Which 8-K item covers a delisting notice?
Item 3.01, "Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard". The same code also covers regaining compliance, so the direction comes from the filing text rather than the code.
How early is an 8-K delisting notice?
It is the earliest public disclosure of the deficiency in most cases, because the company is required to report the notice rather than wait for the exchange to act on it.
Try it
Run this query against the live data before you decide.
The playground calls the real endpoint and shows the real response body, filters included. A free key needs no card and covers both products.